Facilitated By

San Antonio Medical Foundation

News

  • ORIC Pharmaceuticals Presents Preclinical Data on Glucocorticoid Receptor Antagonist at 2019 ...

    ... with nab-paclitaxel in patients with advanced solid tumors, at the 2019 San Antonio Breast Cancer Symposium. ... ORIC is funded by leading biotechnology investors and is headquartered in South San Francisco, California.

  • IFF to merge with DuPont Nutrition and Biosciences unit

    NEW YORK (AP) — International Flavors and Fragrances is merging with DuPont's Nutrition and Biosciences unit in a $26.2 billion deal that would ...

  • Puma Biotechnology INC (Call) (PBYI) Shares Declined While Orbimed Advisors LLC Decreased ...

    D E Shaw And invested 0% of its portfolio in Puma Biotechnology, Inc. ... HER2 Non-Amplified, Metastatic Breast Cancer at the 2019 San Antonio ...

  • How Analysts Feel About Anixa Biosciences, Inc. (ANIX) After Touching Yearly Low?

    ... up Urology San Antonio for Cchek prostate cancer study – Seeking Alpha” on October 25, 2019. More interesting news about Anixa Biosciences, ...

  • 'Post-chemical world' takes shape as agribusiness goes green

    Much of the research in crop biotech is centered in the U.S., China, Germany, Japan and South Korea, though it's being adapted to meet local ...